GLP1R and neuroendocrine neoplasm: Furthermore, they found alpha cell hyperplasia, neuroendocrine tumors, and microadenoma formation, giving more weight to concerns regarding the proliferative actions of GLP-1 therapy and a possible increased risk of neuroendocrine tumors [48].